Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
5.65
-0.16 (-2.75%)
At close: Jun 26, 2026, 4:00 PM EDT
5.61
-0.04 (-0.71%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Nuvation Bio Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Nuvation Bio stock have an average target of 13.17, with a low estimate of 7.00 and a high estimate of 20. The average target predicts an increase of 133.10% from the current stock price of 5.65.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 26, 2026.
Analyst Ratings
The average analyst rating for Nuvation Bio stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 7 | 7 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 10, 2026 |
| TD Cowen | TD Cowen | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 1, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $17 | Buy | Reiterates | $17 | +200.88% | May 26, 2026 |
| B. Riley Securities | B. Riley Securities | Buy Maintains $12 | Buy | Maintains | $12 | +112.39% | May 21, 2026 |
| Wedbush | Wedbush | Buy Maintains $11 | Buy | Maintains | $11 | +94.69% | May 5, 2026 |
Financial Forecast
Revenue This Year
202.59M
from 62.90M
Increased by 222.07%
Revenue Next Year
290.27M
from 202.59M
Increased by 43.28%
EPS This Year
-0.28
from -0.49
EPS Next Year
-0.06
from -0.28
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 215.5M | 357.9M | |
| Avg | 202.6M | 290.3M | |
| Low | 181.6M | 218.7M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 242.6% | 76.7% | |
| Avg | 222.1% | 43.3% | |
| Low | 188.7% | 8.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.28 | -0.06 | |
| Avg | -0.28 | -0.06 | |
| Low | -0.28 | -0.06 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.